Announcements Trials
Browse Landscape

Phase

Phase 2 106Phase 3 48Phase 1 25Phase 1/2 22Phase 4 18Phase NA 14Phase 2/3 12Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Rhabdoid Tumor 2Medulloblastoma 2Ependymoma 2Brain Neoplasms 2Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Muscle Invasive Bladder Urothelial Carcinoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Large Granular Lymphocytic 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 4Sirolimus 2Magnetic Resonance Spectroscopy 2Etoposide 2venetoclax 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1daratumumab 1copanlisib 1alovudine 1X-Rays 1Whole-Body Irradiation 1Vincristine 1Transplantation Conditioning 1Transplantation 1Stem Cell Transplantation 1Spinal Puncture 1Specimen Handling 1Pneumococcal Vaccines 1Photopheresis 1Phantoms, Imaging 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Mycophenolic Acid 1Methotrexate 1Mesna 1Mesenchymal Stem Cell Transplantation 1Leukapheresis 1Influenza Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Methotrexate × Clear all
NCT01184885 2025-05-04

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
7 enrolled 8 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Recurrence, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡